InvestSMART

Acrux Limited (ASX: ACR) - Announcements

Current share price for ACR : $0.010 0.001 (9.09%)+

ASX company news and announcements for Acrux Limited (ACR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acrux Limited (ACR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acrux Limited (ACR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acrux Limited (ACR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Annual General Meeting Script 12 Nov 2020 9:55AM $0.170 $0.010 fallen by 94.12%
$6 Annual General Meeting Presentation 12 Nov 2020 9:54AM $0.170 $0.010 fallen by 94.12%
$6 Receipt of R&D Tax Incentive Rebate - Acrux Commercial 27 Oct 2020 11:01AM $0.175 $0.010 fallen by 94.29%
$6 Receipt of R&D Tax Incentive Rebate - Acrux Pharma Pty Ltd 15 Oct 2020 10:36AM $0.180 $0.010 fallen by 94.44%
$6 Acrux Signs Licensing Agreement with Dash Pharmaceuticals 12 Oct 2020 8:12AM $0.180 $0.010 fallen by 94.44%
$6 AGM - Virtual Meeting Online Guide 5 Oct 2020 11:11AM $0.180 $0.010 fallen by 94.44%
$6 Notice of Annual General Meeting and Proxy Form 5 Oct 2020 11:09AM $0.180 $0.010 fallen by 94.44%
$6 Annual Report to shareholders 16 Sep 2020 1:11PM $0.190 $0.010 fallen by 94.74%
$6 Change of Director's Interest Notice 15 Sep 2020 12:53PM $0.180 $0.010 fallen by 94.44%
$6 Appendix 2A 15 Sep 2020 12:52PM $0.180 $0.010 fallen by 94.44%
$6 Acrux Investor Presentation 25 Aug 2020 8:01AM $0.175 $0.010 fallen by 94.29%
$6 Appendix 4G and Corporate Governance Statement 24 Aug 2020 7:11PM $0.175 $0.010 fallen by 94.29%
$6 Appendix 4E and Full Year Statutory Accounts 24 Aug 2020 7:10PM $0.175 $0.010 fallen by 94.29%
$6 Acrux Signs Licensing Agreement with Harris Pharmaceutical 11 Aug 2020 8:15AM $0.160 $0.010 fallen by 93.75%
$6 Change of Director's Interest Notice 15 Jul 2020 4:01PM $0.160 $0.010 fallen by 93.75%
$6 Appendix 2A 15 Jul 2020 3:59PM $0.160 $0.010 fallen by 93.75%
$6 Acrux Code of Conduct 25 Jun 2020 10:53AM $0.160 $0.010 fallen by 93.75%
$6 Acrux Signs Co-Development Agreement With Amring 18 Jun 2020 9:00AM $0.160 $0.010 fallen by 93.75%
$6 Appendix 2A 15 Jun 2020 12:16PM $0.160 $0.010 fallen by 93.75%
$6 Acrux Signs Licensing Agreement With TruPharma 29 May 2020 8:57AM $0.135 $0.010 fallen by 92.59%
$6 Trading Halt 27 May 2020 10:08AM $0.135 $0.010 fallen by 92.59%
$6 Acrux TGA Audit Outcome 16 Apr 2020 8:25AM $0.145 $0.010 fallen by 93.10%
$6 Appendix 2A 15 Apr 2020 12:00PM $0.145 $0.010 fallen by 93.10%
$6 Company Update - COVID-19 20 Mar 2020 1:02PM $0.110 $0.010 fallen by 90.91%
$6 Change of Director's Interest Notice 16 Mar 2020 5:51PM $0.120 $0.010 fallen by 91.67%

351 - 375 of 709 results

Page 15 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.